Risk factors for brain relapse in HER2-positive metastatic breast cancer patients-Reference-Cited by-同舟云学术

Risk factors for brain relapse in HER2-positive metastatic breast cancer patients

Published:2009-01-07 Issue:2 Volume:117 Page:297-303
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Duchnowska Renata,Dziadziuszko Rafał,Czartoryska-Arłukowicz Bogumiła,Radecka Barbara,Szostakiewicz Barbara,Sosińska-Mielcarek Katarzyna,Karpińska Agnieszka,Starosławska Elżbieta,Kubiatowski Tomasz,Szczylik Cezary

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-0275-z.pdf

Reference46 articles.

1. Flowers A, Levin VA (1993) Management of brain metastases from breast carcinoma. Oncology 7:21–26

2. Tsukada Y, Fouad A, Pickren JW, Lane WW (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52:2349–2354. doi:10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B

3. Freilich RJ, Seidman AD, DeAngelis LM (1995) Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 76:232–236. doi:10.1002/1097-0142(19950715)76:2<232::AID-CNCR2820760212>3.0.CO;2-0

4. Crivellari D, Pagani O, Veronesi A et al (2001) High incidence of central nervous system involment in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol 12:353–356. doi: 10.1023/A:1011132609055

5. Miller KD, Weathers T, Haney LG et al (2003) Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on survival. Ann Oncol 14:1072–1077. doi: 10.1093/annonc/mdg300

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors of breast cancer brain metastasis;World Journal of Clinical Oncology;2024-01-24

2. Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review;BMC Cancer;2021-08-28

3. Pathologic response rates for breast cancer stages as a predictor of outcomes in patients receiving neoadjuvant chemotherapy followed by breast-conserving surgery;Surgical Oncology;2021-03

4. Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study;The Breast;2020-12

5. Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis;The Breast;2020-12